Thyroid C-mobile Tumors: In rodent reports, semaglutide has been revealed to result in thyroid C-cell tumors. It's not known no matter if this threat relates to people, but semaglutide is contraindicated in individuals with a personal or loved ones background of medullary thyroid carcinoma (MTC) or patients with Numerous Endocrine Neoplasia syndrom